May 15 2017, JRSIS HEALTH CARE CORPORATION（JRSS）, a full medical service hospital group serving in Harbin City of Heilongjiang, announced financial result for the first quarters ended March 31, 2017.
“JRSS had another strong performance this quarter with revenue increased 25% than thesame period last year, the total revenue was $5.51 Million,“Said Xuewei Zhang, CFO of JRSS. “We continue to be excited about the growth in our healthcare businesses.”
Financial Summary for the three months ended March 31, 2017 and 2016
JRSIS HEALTH CARE CORPORATION reported consolidated revenues of $5.51 million for the three months ended Marth 31, 2017 an increase of 25% compared to the same period of 2016. The increase was primarily as result of the number of treated inpatients growing to 4,398 patients, 644 more than the 3,754 patients treated in three months ended March 31, 2016.
For the three months ended March 31, 2017, Net income was $1.59 million, an increase of $0.23 million or 17% compared to the same period of 2016. EBITDA was $2.18 million, an increase of 12% compared to the same period of 2016. For the three months ended March 31, 2017 and 2016 total operating costs and expenses was $3.92 million and $3.05 million,respectively.
Revenues-JRSS had another strong performance this quarter, with revenue increased 25% compared to the same period of 2016, was $5.51 million.
Property and equipment-JRSS purchased $0.81 million worth equipment for the hospital for the first quarter of 2017.
This press release includes certain statements that may be deemed to be “forward-looking statements” within the meaning of Section 27 A of the Securities Act of 1933, as amended, and Section 21 E of the Securities Exchange Act of 1934, as amended. All statements included in this press release, other than statements of historical facts, address matters that JRSIS HEALTH CARE CORPORATION (“the company“or“JRSS”) reasonably expects, believes or anticipates will or may occur in the future. These statements are made on the basis of management‘s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. Such statements are subject to various as sumptions, risks and uncertainties. In vestors are cautioned that any such statements are not guarantees of future performance and that actual results or developments may differ materially as those discussed in the JRSS‘s reports filed with the Securities and Exchange Commission from time to time.
More information about JRSS: